| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/17/2004 | US20040115175 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 06/17/2004 | US20040115133 High bioavailability pain relief; masking agent for easier delivery; nose spray |
| 06/17/2004 | CA2508581A1 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/17/2004 | CA2507609A1 Method and compositions for treating anxiety |
| 06/17/2004 | CA2507036A1 Materials and methods for treating ocular-related disorders |
| 06/17/2004 | CA2504740A1 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
| 06/17/2004 | CA2503973A1 Material compositions and related systems and methods for treating cardiac conditions |
| 06/16/2004 | EP1428521A2 Antiperspirant or deodorant composition |
| 06/16/2004 | EP1427711A1 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
| 06/16/2004 | EP1427423A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 06/16/2004 | EP1427414A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines |
| 06/16/2004 | EP1268469B1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 06/16/2004 | EP1255751B1 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors |
| 06/16/2004 | EP1200096B1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 06/16/2004 | EP1196418B1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES |
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/16/2004 | CN1505636A Pharmaceutically active uridine esters |
| 06/16/2004 | CN1505631A Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonist and antagonists ligands |
| 06/16/2004 | CN1505614A Process for making amlodipine maleate |
| 06/16/2004 | CN1505525A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 06/16/2004 | CN1505512A A stable pharmaceutical formulation comprising torsemide modification II |
| 06/16/2004 | CN1505506A Carbamate compounds for use in preventing or treating bipolar disorder |
| 06/16/2004 | CN1153780C Protein with thrombopoiesis substance activity |
| 06/16/2004 | CN1153773C Salts of optically active sulfoxide derivative |
| 06/16/2004 | CN1153764C Substituted benzylaminopiperidine compounds |
| 06/16/2004 | CN1153589C Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 06/16/2004 | CN1153510C Vaccination against coccidiosis in ovum |
| 06/15/2004 | US6750245 C7 carbamate substituted taxanes |
| 06/15/2004 | US6750009 Multiple viral replicon culture systems |
| 06/13/2004 | CA2451296A1 Cosmetic method and composition for enhancing attractiveness |
| 06/10/2004 | WO2004047848A1 New use of dextran sulfate |
| 06/10/2004 | WO2004047788A2 Functional fragrance precursor |
| 06/10/2004 | WO2004047767A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047765A2 Compositions, methods, and kits for weight loss and inhibiting the loss of lean body mass |
| 06/10/2004 | WO2004047763A2 Production of ubiquinones |
| 06/10/2004 | WO2004047762A2 Methods for treating cancer using porimin as a target |
| 06/10/2004 | WO2004047753A2 Freeze-drying microscope stage apparatus and process of using the same |
| 06/10/2004 | WO2004047748A2 Water soluble compositions derived from plant material and preparation thereof |
| 06/10/2004 | WO2004047746A2 Regulation of stearoyl-coa desaturase to treat obesity |
| 06/10/2004 | WO2004047741A2 Modulation of iap-like expression |
| 06/10/2004 | WO2004047737A2 Nucleotide based medicament and method of use for treatment of conditions in humans |
| 06/10/2004 | WO2004047736A2 Modulation of bcl2-associated athanogene expression |
| 06/10/2004 | WO2004047735A2 Broad spectrum anti-viral therapeutics and prophylaxis |
| 06/10/2004 | WO2004047730A2 Compounds for inhibition of hiv infection by blocking hiv entry |
| 06/10/2004 | WO2004047728A2 Compositions and methods for the treatment of immune related diseases |
| 06/10/2004 | WO2004047727A2 Compositions and methods for diagnosing and treating mood disorders |
| 06/10/2004 | WO2004047725A2 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 06/10/2004 | WO2004047723A2 Method for producing fine highly porous silicium dioxide |
| 06/10/2004 | WO2004047721A2 A process for preparation of an agglutination reagent for rapid detection of typhoid |
| 06/10/2004 | WO2004047720A2 Methods of inhibiting angiogensis via modification of a lysyl oxidase |
| 06/10/2004 | WO2004047717A2 Topical application of curcumin for the treatment of peripheral neuropathy |
| 06/10/2004 | WO2004047623A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047514A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004034995A9 Methods and reagents for inducing immunity |
| 06/10/2004 | WO2004026262A3 Abuse-resistant pharmaceutical compositions |
| 06/10/2004 | WO2004022000A3 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 06/10/2004 | WO2004012680A3 Lipid-drug complexes in reversed liquid and liquid crystalline phases |
| 06/10/2004 | WO2003090692A9 Make-up applicator with led light source |
| 06/10/2004 | US20040110841 Antiseptic compositions, methods and systems |
| 06/10/2004 | US20040110806 Dipeptide derivatives |
| 06/10/2004 | US20040110738 Administering silver- or metal compound as microbiocidal, anti-biofilm, bactericidal, antiinflammatory, fungicidal, viricidal and/or anticarcinogenic agent; skin disorders, dentistry |
| 06/10/2004 | US20040110710 Methods of reducing ischemic injury |
| 06/10/2004 | US20040110691 Thiol reactive agents as a therapeutic modality |
| 06/10/2004 | US20040110203 Screening for a test agent that increases or induces a component of the p21 signal transduction pathway, thereby reducing the appearance or formation of wrinkles; used in fragrance or sunscreen |
| 06/10/2004 | US20040110195 Clinical assays for the detection and typing of human herpesviruses |
| 06/10/2004 | US20040109902 Dermatological formulations |
| 06/10/2004 | CA2839591A1 Functional fragrance precursor |
| 06/10/2004 | CA2839590A1 Functional fragrance precursor |
| 06/10/2004 | CA2839580A1 Functional fragrance precursor |
| 06/10/2004 | CA2839576A1 Functional fragrance precursor |
| 06/10/2004 | CA2507887A1 Nucleotide based medicament and method of use for treatment of conditions in humans |
| 06/10/2004 | CA2507215A1 Methods for treating cancer using porimin as a target |
| 06/10/2004 | CA2507023A1 Functional fragrance precursor |
| 06/10/2004 | CA2506526A1 Broad spectrum anti-viral therapeutics and prophylaxis |
| 06/10/2004 | CA2505784A1 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | CA2504144A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 06/10/2004 | CA2503246A1 Compositions and methods for diagnosing and treating mood disorders |
| 06/10/2004 | CA2498566A1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 06/09/2004 | EP1425008A1 Use of substituted aminomethyl chromans in the treatment of movement disorders |
| 06/09/2004 | EP1425005A1 Pharmaceutical compostion comprising lumiracoxib |
| 06/09/2004 | EP1198237B1 Herbal compositions for itchy or infected skin |
| 06/09/2004 | EP1180102B1 Mutual prodrugs of amlodipine and atorvastatin |
| 06/09/2004 | EP1098897B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/09/2004 | EP0964671B1 Clear antiperspirant or deodorant gel composition with volatile linear silicone to reduce staining |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152880C Process for preparation of oxymorphone, oxycodone and derivatives |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/09/2004 | CN1152681C 8a-azalides as veterinary antimicrobial agents for animals |
| 06/08/2004 | US6747158 Anticoagulants |
| 06/08/2004 | US6747054 EP4 receptor selective agonists in the treatment of osteoporosis |
| 06/08/2004 | US6747036 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia |
| 06/03/2004 | WO2004046115A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 06/03/2004 | WO2004046068A2 Non-steroidal farnesoid x receptor modulators and methods for the use thereof |
| 06/03/2004 | WO2004045640A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | WO2004045561A2 Use of ferritin for immunomodulation |
| 06/03/2004 | WO2004045559A2 Method for the prevention of malaria |
| 06/03/2004 | WO2004045558A2 Compositions and methods for treating thrombotic disorders |
| 06/03/2004 | WO2004045557A2 Novel lapachone compounds and methods of use thereof |
| 06/03/2004 | WO2004045554A2 Cytomodulating peptides for treating interstitial cystitis |